|
1
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Butcher EC, Williams M, Youngman K, Rott L
and Briskin M: Lymphocyte trafficking and regional immunity. Adv
Immunol. 72:209–253. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Campbell JJ and Butcher EC: Chemokines in
tissue-specific and microenvironment-specific lymphocyte homing.
Curr Opin Immunol. 12:336–341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morales J, Homey B, Vicari AP, Hudak S,
Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM,
et al: CTACK, a skin-associated chemokine that preferentially
attracts skin-homing memory T cells. Proc Natl Acad Sci USA.
96:14470–14475. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zlotnik A and Yoshie O: Chemokines: A new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van den Bosch T, Koopmans AE, Vaarwater J,
van den Berg M, de Klein A and Verdijk RM: Chemokine receptor CCR7
expression predicts poor outcome in uveal melanoma and relates to
liver metastasis whereas expression of CXCR4 is not of clinical
relevance. Invest Ophthalmol Vis Sci. 54:7354–7361. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Lou W, Ji Y and Zhang S: Effect of
CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human
pancreatic ductal adenocarcinoma. Oncol Lett. 5:1572–1578.
2013.PubMed/NCBI
|
|
8
|
Wang WN, Chen Y, Zhang YD and Hu TH: The
regulatory mechanism of CCR7 gene expression and its involvement in
the metastasis and progression of gastric cancer. Tumour Biol.
34:1865–1871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and
Sun CF: CCL19-induced chemokine receptor 7 activates the
phosphoinositide-3 kinase-mediated invasive pathway through Cdc42
in metastatic squamous cell carcinoma of the head and neck. Oncol
Rep. 25:729–737. 2011.
|
|
10
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through MAPKs in metastatic squamous cell carcinoma of head and
neck. Int J Oncol. 45:2502–2510. 2014.PubMed/NCBI
|
|
11
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through JAK2/STAT3 in metastatic squamous cell carcinoma of the
head and neck. Biomed Res Int. 2014:4153752014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang L, Liu F, Xu Z, Guo N, Zheng X and
Sun C: Chemokine receptor 7 via proline-rich tyrosine kinase-2
upregulates the chemotaxis and migration ability of squamous cell
carcinoma of the head and neck. Oncol Rep. 28:1659–1664.
2012.PubMed/NCBI
|
|
13
|
Wang J, Zhang X, Thomas SM, Grandis JR,
Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates
phosphoinositide-3 kinase-mediated invasive and prosurvival
pathways in head and neck cancer cells independent of EGFR.
Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mburu YK, Wang J, Wood MA, Walker WH and
Ferris RL: CCR7 mediates inflammation-associated tumor progression.
Immunol Res. 36:61–72. 2006. View Article : Google Scholar
|
|
15
|
Xiong WC, Macklem M and Parsons JT:
Expression and characterization of splice variants of PYK2, a focal
adhesion kinase-related protein. J Cell Sci. 111:1981–1991.
1998.PubMed/NCBI
|
|
16
|
Zhao ZJ, Liu FY and Sun CF: Effect of
chemokine receptor 7 small interfering RNA on proliferation and
invasion of squamous cell carcinoma of head and neck. Zhonghua Kou
Qiang Yi Xue Za Zhi. 44:5–10. 2009.In Chinese. PubMed/NCBI
|
|
17
|
Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang
LL, Zong ZH and Sun CF: NF-κB participates in chemokine receptor
7-mediated cell survival in metastatic squamous cell carcinoma of
the head and neck. Oncol Rep. 25:383–391. 2011.
|
|
18
|
Liu FY, Zhao ZJ, Li P, Ding X and Sun CF:
The effect of CCL19 on the viability of head and neck squamous
cancer cells. Shanghai Kou Qiang Yi Xue. 19:158–161. 2010.In
Chinese. PubMed/NCBI
|
|
19
|
Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and
Sun CF: Mammalian target of rapamycin (mTOR) is involved in the
survival of cells mediated by chemokine receptor 7 through PI3K/Akt
in metastatic squamous cell carcinoma of the head and neck. Br J
Oral Maxillofac Surg. 48:291–296. 2010. View Article : Google Scholar
|
|
20
|
Guo N, Liu F, Yang L, Huang J, Ding X and
Sun C: Chemokine receptor 7 enhances cell chemotaxis and migration
of metastatic squamous cell carcinoma of head and neck through
activation of matrix metalloproteinase-9. Oncol Rep. 32:794–800.
2014.PubMed/NCBI
|
|
21
|
Ziemka-Nalecz M, Jaworska J, Sypecka J and
Zalewska T: OGD induced modification of FAK-and PYK2-coupled
pathways in organotypic hippocampal slice cultures. Brain Res.
1606:21–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lipinski CA, Tran NL, Bay C, Kloss J,
McDonough WS, Beaudry C, Berens ME and Loftus JC: Differential role
of proline-rich tyrosine kinase 2 and focal adhesion kinase in
determining glioblastoma migration and proliferation. Mol Cancer
Res. 1:323–332. 2003.PubMed/NCBI
|
|
23
|
Sun CK, Ng KT, Lim ZX, Cheng Q, Lo CM,
Poon RT, Man K, Wong N and Fan ST: Proline-rich tyrosine kinase 2
(Pyk2) promotes cell motility of hepatocellular carcinoma through
induction of epithelial to mesenchymal transition. PLoS One.
6:e188782011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: An imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng
Q, Lo CM, Poon RT and Fan ST: Proline-rich tyrosine kinase 2 (Pyk2)
promotes proliferation and invasiveness of hepatocellular carcinoma
cells through c-Src/ERK activation. Carcinogenesis. 29:2096–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Datta A, Bhasin N, Kim H, Ranjan M, Rider
B, Abd Elmageed ZY, Mondal D, Agrawal KC and Abdel-Mageed AB:
Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone
abrogates doxorubicin resistance in breast cancer cells. Cancer
Lett. 362:25–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li P, Liu F, Sun L, Zhao Z, Ding X, Shang
D, Xu Z and Sun C: Chemokine receptor 7 promotes cell migration and
adhesion in metastatic squamous cell carcinoma of the head and neck
by activating integrin αvβ3. Int J Mol Med. 27:679–687.
2011.PubMed/NCBI
|
|
28
|
Li P, Zhao ZJ, Liu FY, Sun LY, Ding X,
Zhang WZ, Shang DH and Sun CF: The chemokine receptor 7 regulates
cell adhesion and migration via β1 integrin in metastatic squamous
cell carcinoma of the head and neck. Oncol Rep. 24:989–995.
2010.PubMed/NCBI
|
|
29
|
Vleminckx K, Vakaet L Jr, Mareel M, Fiers
W and van Roy F: Genetic manipulation of E-cadherin expression by
epithelial tumor cells reveals an invasion suppressor role. Cell.
66:107–119. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Frixen UH, Behrens J, Sachs M, Eberle G,
Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated
cell-cell adhesion prevents invasiveness of human carcinoma cells.
J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Savagner P: Leaving the neighborhood:
Molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
